MT4-MMP/NRP1 axis is required for balanced angiogenesis in the embryonic brain

This study identifies the GPI-anchored protease MT4-MMP as a critical regulator of embryonic brain angiogenesis that maintains vascular balance by cleaving the co-receptor NRP1 to modulate VEGFA-induced ERK signaling, thereby preventing excessive vessel formation.

The Gist

Imagine the developing brain of an embryo as a bustling construction site. The goal is to build a complex, efficient network of "roads" (blood vessels) to deliver oxygen and nutrients to the growing city (the brain). This process is called angiogenesis.

For a long time, scientists knew that the main "foreman" of this construction was a signal called VEGFA. It tells the road-builders (endothelial cells) where to go and how fast to build. But the construction site is chaotic; if the foreman shouts too loud or too long, the roads get messy, overcrowded, and poorly organized.

This paper discovers a new, crucial "traffic controller" named MT4-MMP that ensures the construction stays balanced. Here's how it works, broken down into simple concepts:

1. The Traffic Controller (MT4-MMP)

Think of MT4-MMP as a specialized construction manager who carries a pair of "molecular scissors." Its job isn't to build the roads itself, but to trim the instructions being sent to the workers.

• What it cuts: It targets a protein called NRP1. You can think of NRP1 as a "megaphone" attached to the road-builders. This megaphone amplifies the VEGFA signal, making the builders work harder and faster.
• The Action: MT4-MMP snips the top off the NRP1 megaphone. This doesn't destroy the builder, but it turns the volume down just enough so they don't go crazy.

2. The Two Scenarios: Too Much vs. Too Little

The researchers tested what happens when this traffic controller is missing, and the results were surprisingly different depending on where it was missing.

• Scenario A: The Global Shutdown (The Whole Site is Quiet)
  When MT4-MMP is missing from everywhere (including the surrounding neural cells), the construction site actually slows down. The roads become sparse and disconnected.

  • Why? It seems that without MT4-MMP, the "megaphones" (NRP1) get confused or blocked by other cells, and the builders can't hear the VEGFA signal clearly enough to start building.

• Scenario B: The Selective Shutdown (Only the Builders are Quiet)
  When the researchers removed MT4-MMP only from the road-builders (endothelial cells), the site went into chaos. The roads became a tangled, overcrowded mess with too many intersections and dilated (stretched out) vessels.

  • Why? Without the scissors to trim the NRP1 megaphone, the signal from VEGFA becomes too loud and sustained. The builders get hyper-activated, over-proliferate, and build a messy, inefficient network.

3. The "Volume Knob" Analogy

Think of the VEGFA signal as music playing at a party.

• NRP1 is the volume knob.
• MT4-MMP is the person who gently turns the volume down every few minutes so the music doesn't get deafening.
• Without MT4-MMP: The volume knob gets stuck at "Maximum." The music (signaling) is so loud that the party (the brain) gets chaotic, and people (cells) start dancing in circles instead of moving in a straight line.

4. The Proof: Turning the Volume Down

To prove this theory, the scientists gave the chaotic construction sites a drug that acts like a "mute button" for the NRP1 megaphone.

• Result: When they silenced the NRP1 signal in the chaotic, MT4-MMP-deficient brains, the messy, overcrowded roads became organized again. This confirmed that the chaos was caused specifically by the NRP1 signal being too loud.

5. Why This Matters

This discovery is like finding a missing piece of the instruction manual for building a brain.

• Development: It explains how the brain creates a perfectly balanced vascular network. If this "scissors" mechanism fails, it could lead to vascular malformations (tangled or weak blood vessels) in the brain.
• Disease: This same mechanism might be relevant in adult diseases. For example, in some cancers or vascular disorders, the "volume" of these signals might be stuck too high.
• Healing: The researchers also found this mechanism works in skin wound healing. When MT4-MMP is missing, wounds heal faster because the blood vessels grow too aggressively. This suggests we might be able to use this knowledge to help heal chronic wounds or treat vascular diseases.

In a nutshell: The brain needs a delicate balance of signals to build its blood vessels. MT4-MMP is the essential "trimmer" that cuts the NRP1 signal just enough to keep the construction organized. Without it, the signal gets too loud, and the brain's vascular network becomes a tangled mess.

Technical Summary

1. Problem Statement

Embryonic angiogenesis in the central nervous system (CNS) is a tightly regulated process essential for brain development and the formation of the blood-brain barrier. While VEGFA signaling is known to be the primary driver, the spatiotemporal mechanisms that fine-tune this signaling to prevent excessive or insufficient vascularization remain poorly understood. Specifically, the role of the co-receptor Neuropilin-1 (NRP1) is critical, yet how its activity is dynamically regulated during development is unclear. Additionally, the contribution of Matrix Metalloproteinases (MMPs), particularly the GPI-anchored protease MT4-MMP, to endothelial cell function and developmental angiogenesis had not been fully elucidated.

2. Methodology

The study employed a multidisciplinary approach combining in vivo mouse models, in vitro cell assays, proteomics, and computational modeling:

• Animal Models:
  • Global Knockout: Mt4-mmp^-/- mice (C57BL/6 background).
  • Conditional Knockout: Endothelial cell-specific deletion (Mt4-mmp^iΔEC) generated by crossing Mt4-mmp^loxP/loxP mice with Cdh5-CreERT2 mice. Tamoxifen was administered to pregnant females (E7.5–E9.5) to induce deletion.
  • Reporter Mice: Mt4-mmp^LacZ/+ to visualize expression patterns.
  • Pharmacological Intervention: Pregnant females were treated with EG00229, a specific inhibitor of NRP1-VEGFA binding, to test rescue effects.
• Phenotypic Analysis:
  • Whole-mount Immunofluorescence: Hindbrains at E10.5–E12.5 were stained with Isolectin B4 (IB4) and anti-ERG to visualize vascular plexus structure.
  • Quantification: Vascular density, length, junctions, lacunarity, and vessel diameter were quantified using AngioTool and ImageJ.
  • Wound Healing: Skin wound assays were performed in adult mice to assess angiogenesis in tissue repair contexts.
• Molecular & Cellular Assays:
  • In Vitro Migration/Polarization: Scratch assays on Mouse Aortic Endothelial Cells (MAEC) from WT and KO mice to assess polarization (Nucleus-Golgi axis) and migration speed.
  • Signaling Pathways: Western blotting for phosphorylated ERK (pERK), pPLCβ3, and p38 MAPK following VEGFA stimulation.
  • Substrate Identification: SILAC proteomics on bone marrow-derived cells, co-transfection of HEK293 cells with NRP1-EGFP and MT4-MMP (WT vs. catalytic mutant E248A), and in vitro digestion assays using recombinant proteins.
  • Binding Assays: VEGFA₁₆₅-Alkaline Phosphatase (AP) binding assays on embryonic hindbrains.
• Computational Modeling:
  • In Silico Modeling: Rosetta and I-TASSER were used to model the NRP1/MT4-MMP complex.
  • Molecular Dynamics (MD): GROMACS simulations were performed to analyze the interaction between NRP1 and MT4-MMP in lipid bilayers with varying phosphatidylserine (PS) content.

3. Key Contributions

• Discovery of a Novel Substrate: The study identifies NRP1 as a direct substrate of the GPI-anchored protease MT4-MMP.
• Mechanism of Regulation: It demonstrates that MT4-MMP cleaves NRP1 at a specific site (S458Y in the b2 domain), a process facilitated by the recruitment of NRP1 to lipid domains (enriched in phosphatidylserine).
• Context-Dependent Phenotypes: The paper reveals that the loss of MT4-MMP has opposite effects on angiogenesis depending on the cellular context:
  • Global Loss: Leads to reduced angiogenesis (mimicking NRP1 deficiency).
  • Endothelial-Specific Loss: Leads to exacerbated angiogenesis (mimicking VEGFA/NRP1 overactivity).
• Signaling Axis Definition: It defines a new MT4-MMP/NRP1/VEGFA/ERK axis where MT4-MMP acts as a negative regulator of NRP1-mediated VEGFA signaling to ensure balanced vascular patterning.

4. Key Results

• Phenotypic Divergence:
  • Global KO (Mt4-mmp^-/-): At E11.5, hindbrains showed reduced vascular density, fewer junctions, and increased lacunarity. This phenotype resembled NRP1 mutants.
  • Endothelial-Specific KO (Mt4-mmpiΔEC): At E11.5, hindbrains showed exacerbated angiogenesis with disorganized, highly branched, and dilated vessels. This phenotype resembled the effects of heparin-binding VEGFA isoforms.
  • Transient Nature: The vascular defects in Mt4-mmpiΔEC embryos were transient, resolving by E12.5.
• Cellular Mechanisms:
  • Polarization & Migration: Mt4-mmp^-/- endothelial cells in scratch assays showed mis-polarization and faster migration.
  • Signaling: In the absence of MT4-MMP, VEGFA-induced ERK phosphorylation was sustained and elevated (rather than biphasic), and pPLCβ3 levels were higher. p38 MAPK signaling remained unchanged.
• NRP1 as a Substrate:
  • Proteomics & Digestion: NRP1 was identified as a candidate substrate. In vitro digestion confirmed MT4-MMP cleaves recombinant NRP1, generating a C-terminal fragment.
  • Surface Levels: In Mt4-mmp^-/- cells (both in vitro and in vivo skin wounds), surface NRP1 levels were significantly increased compared to WT, confirming MT4-MMP normally sheds NRP1.
  • Cleavage Site: Modeling and digestion assays pinpointed S458Y in the b2 domain as the cleavage site. This cleavage removes the VEGFA-binding domains (b1/b2) but preserves the cytosolic tail and adhesion domains.
  • Lipid Environment: MD simulations showed that a membrane with 20% phosphatidylserine (PS) in the outer leaflet significantly shortens the distance between NRP1 and MT4-MMP, facilitating cleavage.
• Rescue Experiment:
  • Treatment of Mt4-mmpiΔEC embryos with the NRP1 inhibitor EG00229 (blocking VEGFA-NRP1 binding) partially rescued the exacerbated angiogenic phenotype, reducing vascular density and restoring patterning.
• Signaling Correlation:
  • pERK levels were increased in the vasculature of Mt4-mmpiΔEC embryos (correlating with hyper-angiogenesis) but decreased in global Mt4-mmp^-/- embryos (correlating with hypo-angiogenesis).

5. Significance

• Novel Regulatory Axis: The study establishes a critical feedback loop where MT4-MMP modulates the sensitivity of endothelial cells to VEGFA by cleaving NRP1. This prevents excessive ERK signaling and ensures proper vascular branching.
• Spatiotemporal Control: The findings explain how the same protease can regulate angiogenesis differently depending on whether it is absent in endothelial cells alone or in the entire microenvironment (including neural progenitors).
• Clinical Relevance:
  • Vascular Malformations: Dysregulation of this axis (e.g., via ERK hyperactivation) may contribute to congenital vascular malformations (AVMs, Sturge-Weber syndrome).
  • Tissue Repair: The axis plays a role in adult wound healing, suggesting potential therapeutic targets for accelerating or controlling tissue repair.
  • Infection: Given NRP1's role as a receptor for SARS-CoV-2 spike protein, MT4-MMP-mediated cleavage could theoretically modulate viral entry, offering a new angle for therapeutic intervention.
• Therapeutic Implications: The identification of the MT4-MMP/NRP1 axis provides new targets for treating CNS vascular abnormalities and neurodegenerative diseases involving vascular dysfunction.

In conclusion, the paper elucidates a precise molecular mechanism where the protease MT4-MMP acts as a "brake" on NRP1-mediated VEGFA signaling during brain development, ensuring that angiogenesis proceeds in a balanced, stereotyped manner.